Your session is about to expire
← Back to Search
EyeTurn App for Crossed Eyes
Study Summary
This trial will test a new smartphone app that screens for and measures eye misalignment (strabismus). The app will be validated against known cases of strabismus and common clinical tests. The app will be evaluated as a screening tool in high risk populations.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research study currently have openings for participants?
"Affirmative. Clinicaltrials.gov indicates that this clinical study is currently recruiting volunteers, having been listed since February 1st of 2018 and last updated on April 16th 2021. The trial seeks to enrol 190 individuals from one primary site."
Is my profile congruent with the criteria for this medical experiment?
"This experiment requires the recruitment of 190 individuals aged 18 to 88 who suffer from strabismus. Applicants must be able to fixate on a visual target for 30-60 seconds and meet other age criteria."
Are participants aged 40 or older accepted for this investigation?
"The study parameters mandate that individuals aged between 18 and 88 may participate. There are 9 trials for minors, while those over 65 years of age have 6 options available to them."
How many individuals have been recruited for participation in this clinical trial?
"Affirmative. According to clinicaltrials.gov, this medical research endeavor is currently enlisting patients; the original posting was on February 1st 2018 and most recent update occurred April 16th 2021. 190 participants are sought from a single site for this study."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger